Cargando…

Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism

Although autism is first and foremost a disorder of the central nervous system, comorbid dysfunction of the gastrointestinal (GI) and immune systems is common, suggesting that all three systems may be affected by common molecular mechanisms. Substantial systemic deficits in the antioxidant glutathio...

Descripción completa

Detalles Bibliográficos
Autores principales: Waly, Mostafa I., Hornig, Mady, Trivedi, Malav, Hodgson, Nathaniel, Kini, Radhika, Ohta, Akio, Deth, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420412/
https://www.ncbi.nlm.nih.gov/pubmed/22934169
http://dx.doi.org/10.1155/2012/190930
_version_ 1782240840898314240
author Waly, Mostafa I.
Hornig, Mady
Trivedi, Malav
Hodgson, Nathaniel
Kini, Radhika
Ohta, Akio
Deth, Richard
author_facet Waly, Mostafa I.
Hornig, Mady
Trivedi, Malav
Hodgson, Nathaniel
Kini, Radhika
Ohta, Akio
Deth, Richard
author_sort Waly, Mostafa I.
collection PubMed
description Although autism is first and foremost a disorder of the central nervous system, comorbid dysfunction of the gastrointestinal (GI) and immune systems is common, suggesting that all three systems may be affected by common molecular mechanisms. Substantial systemic deficits in the antioxidant glutathione and its precursor, cysteine, have been documented in autism in association with oxidative stress and impaired methylation. DNA and histone methylation provide epigenetic regulation of gene expression during prenatal and postnatal development. Prenatal epigenetic programming (PrEP) can be affected by the maternal metabolic and nutritional environment, whereas postnatal epigenetic programming (PEP) importantly depends upon nutritional support provided through the GI tract. Cysteine absorption from the GI tract is a crucial determinant of antioxidant capacity, and systemic deficits of glutathione and cysteine in autism are likely to reflect impaired cysteine absorption. Excitatory amino acid transporter 3 (EAAT3) provides cysteine uptake for GI epithelial, neuronal, and immune cells, and its activity is decreased during oxidative stress. Based upon these observations, we propose that neurodevelopmental, GI, and immune aspects of autism each reflect manifestations of inadequate antioxidant capacity, secondary to impaired cysteine uptake by the GI tract. Genetic and environmental factors that adversely affect antioxidant capacity can disrupt PrEP and/or PEP, increasing vulnerability to autism.
format Online
Article
Text
id pubmed-3420412
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34204122012-08-29 Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism Waly, Mostafa I. Hornig, Mady Trivedi, Malav Hodgson, Nathaniel Kini, Radhika Ohta, Akio Deth, Richard Autism Res Treat Research Article Although autism is first and foremost a disorder of the central nervous system, comorbid dysfunction of the gastrointestinal (GI) and immune systems is common, suggesting that all three systems may be affected by common molecular mechanisms. Substantial systemic deficits in the antioxidant glutathione and its precursor, cysteine, have been documented in autism in association with oxidative stress and impaired methylation. DNA and histone methylation provide epigenetic regulation of gene expression during prenatal and postnatal development. Prenatal epigenetic programming (PrEP) can be affected by the maternal metabolic and nutritional environment, whereas postnatal epigenetic programming (PEP) importantly depends upon nutritional support provided through the GI tract. Cysteine absorption from the GI tract is a crucial determinant of antioxidant capacity, and systemic deficits of glutathione and cysteine in autism are likely to reflect impaired cysteine absorption. Excitatory amino acid transporter 3 (EAAT3) provides cysteine uptake for GI epithelial, neuronal, and immune cells, and its activity is decreased during oxidative stress. Based upon these observations, we propose that neurodevelopmental, GI, and immune aspects of autism each reflect manifestations of inadequate antioxidant capacity, secondary to impaired cysteine uptake by the GI tract. Genetic and environmental factors that adversely affect antioxidant capacity can disrupt PrEP and/or PEP, increasing vulnerability to autism. Hindawi Publishing Corporation 2012 2012-06-19 /pmc/articles/PMC3420412/ /pubmed/22934169 http://dx.doi.org/10.1155/2012/190930 Text en Copyright © 2012 Mostafa I. Waly et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Waly, Mostafa I.
Hornig, Mady
Trivedi, Malav
Hodgson, Nathaniel
Kini, Radhika
Ohta, Akio
Deth, Richard
Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism
title Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism
title_full Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism
title_fullStr Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism
title_full_unstemmed Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism
title_short Prenatal and Postnatal Epigenetic Programming: Implications for GI, Immune, and Neuronal Function in Autism
title_sort prenatal and postnatal epigenetic programming: implications for gi, immune, and neuronal function in autism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420412/
https://www.ncbi.nlm.nih.gov/pubmed/22934169
http://dx.doi.org/10.1155/2012/190930
work_keys_str_mv AT walymostafai prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism
AT hornigmady prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism
AT trivedimalav prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism
AT hodgsonnathaniel prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism
AT kiniradhika prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism
AT ohtaakio prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism
AT dethrichard prenatalandpostnatalepigeneticprogrammingimplicationsforgiimmuneandneuronalfunctioninautism